Citation 124573

CHANG,CH: LIN,CC: HATTORI,M: NAMBA,T:. (1994). EFFECTS ON ANTI-LIPID PEROXIDATION OF CUDRANIA COCHINCHINENSIS VAR. GERONTOGEA.. 44(2)

Citation Details

Title	EFFECTS ON ANTI-LIPID PEROXIDATION OF CUDRANIA COCHINCHINENSIS VAR. GERONTOGEA.
Authors	CHANG,CH: LIN,CC: HATTORI,M: NAMBA,T:
Year	1994
Volume	44
Issue	2

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Maclura cochinchinensis (MORACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIINFLAMMATORY ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
2	ANTIVIRAL ACTIVITY	MEDICINAL FOLKLORE REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	None
3	ANALGESIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
4	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
5	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CUDRAXANTHONE I	None
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CUDRAXANTHONE I	WEAK ACTIVITY
8	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CUDRAXANTHONE I	ACTIVE
9	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	XANTHONE,1-3-7-TRIHYDROXY-2-(BUT-2-ENYL-3-METHYL):	None
10	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-7-TRIHYDROXY-2-(BUT-2-ENYL-3-METHYL):	ACTIVE
11	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHONE,1-3-7-TRIHYDROXY-2-(BUT-2-ENYL-3-METHYL):	ACTIVE
12	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	LANCERIN	None
13	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LANCERIN	INACTIVE
14	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LANCERIN	ACTIVE

Show SPARQL Queries (1)